Lauren E Colbert1, Sarah B Fisher2, Serdar Balci3, Burcu Saka3, Zhengjia Chen4, Sungjin Kim4, Bassel F El-Rayes5, N Volkan Adsay6, Shishir K Maithel7, Jerome C Landry8, Walter J Curran9. 1. Department of Radiation Oncology, Emory University, Atlanta, Georgia; Winship Cancer Institute, Emory University, Atlanta, Georgia; Memorial Sloan-Kettering Cancer Center, New York, New York. 2. Winship Cancer Institute, Emory University, Atlanta, Georgia; Division of Surgical Oncology, Department of Surgery, Emory University, Atlanta, Georgia. 3. Winship Cancer Institute, Emory University, Atlanta, Georgia; Department of Pathology, Emory University, Atlanta, Georgia. 4. Winship Cancer Institute, Emory University, Atlanta, Georgia; Biostatistics and Bioinformatics Shared Resource, Emory University, Atlanta, Georgia. 5. Winship Cancer Institute, Emory University, Atlanta, Georgia; Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia. 6. Winship Cancer Institute, Emory University, Atlanta, Georgia; Department of Pathology, Emory University, Atlanta, Georgia; Biostatistics and Bioinformatics Shared Resource, Emory University, Atlanta, Georgia. 7. Winship Cancer Institute, Emory University, Atlanta, Georgia; Division of Surgical Oncology, Department of Surgery, Emory University, Atlanta, Georgia; Biostatistics and Bioinformatics Shared Resource, Emory University, Atlanta, Georgia. 8. Department of Radiation Oncology, Emory University, Atlanta, Georgia; Winship Cancer Institute, Emory University, Atlanta, Georgia; Biostatistics and Bioinformatics Shared Resource, Emory University, Atlanta, Georgia. 9. Department of Radiation Oncology, Emory University, Atlanta, Georgia; Winship Cancer Institute, Emory University, Atlanta, Georgia; Biostatistics and Bioinformatics Shared Resource, Emory University, Atlanta, Georgia. Electronic address: wcurran@emory.edu.
Abstract
PURPOSE: To evaluate nuclear hypoxia-inducible factor 1α (HIF-1α) expression as a prognostic factor for distant recurrence (DR) and local recurrence (LR) after pancreatic adenocarcinoma resection. METHODS AND MATERIALS: Tissue specimens were collected from 98 patients with pancreatic adenocarcinoma who underwent resection without neoadjuvant therapy between January 2000 and December 2011. Local recurrence was defined as radiographic or pathologic evidence of progressive disease in the pancreas, pancreatic bed, or associated nodal regions. Distant recurrence was defined as radiographically or pathologically confirmed recurrent disease in other sites. Immunohistochemical staining was performed and scored by an independent pathologist blinded to patient outcomes. High HIF-1α overall expression score was defined as high percentage and intensity staining and thus score >1.33. Univariate analysis was performed for HIF-1α score with LR alone and with DR. Multivariate logistic regression was used to determine predictors of LR and DR. RESULTS: Median follow-up time for all patients was 16.3 months. Eight patients (8%) demonstrated isolated LR, 26 patients (26.5%) had isolated DR, and 13 patients had both LR and DR. Fifty-three patients (54%) had high HIF-1α expression, and 45 patients (46%) had low HIF-1α expression. High HIF-1α expression was significantly associated with DR (P=.03), and low HIF-1α expression was significantly associated with isolated LR (P=.03). On multivariate logistic regression analysis, high HIF-1α was the only significant predictor of DR (odds ratio 2.46 [95% confidence interval 1.06-5.72]; P=.03). In patients with a known recurrence, an HIF-1α score ≥2.5 demonstrated a specificity of 100% for DR. CONCLUSIONS: High HIF-1α expression is a significant predictor of distant failure versus isolated local failure in patients undergoing resection of pancreatic adenocarcinoma. Expression of HIF-1α may have utility in determining candidates for adjuvant local radiation therapy and systemic chemotherapy.
PURPOSE: To evaluate nuclear hypoxia-inducible factor 1α (HIF-1α) expression as a prognostic factor for distant recurrence (DR) and local recurrence (LR) after pancreatic adenocarcinoma resection. METHODS AND MATERIALS: Tissue specimens were collected from 98 patients with pancreatic adenocarcinoma who underwent resection without neoadjuvant therapy between January 2000 and December 2011. Local recurrence was defined as radiographic or pathologic evidence of progressive disease in the pancreas, pancreatic bed, or associated nodal regions. Distant recurrence was defined as radiographically or pathologically confirmed recurrent disease in other sites. Immunohistochemical staining was performed and scored by an independent pathologist blinded to patient outcomes. High HIF-1α overall expression score was defined as high percentage and intensity staining and thus score >1.33. Univariate analysis was performed for HIF-1α score with LR alone and with DR. Multivariate logistic regression was used to determine predictors of LR and DR. RESULTS: Median follow-up time for all patients was 16.3 months. Eight patients (8%) demonstrated isolated LR, 26 patients (26.5%) had isolated DR, and 13 patients had both LR and DR. Fifty-three patients (54%) had high HIF-1α expression, and 45 patients (46%) had low HIF-1α expression. High HIF-1α expression was significantly associated with DR (P=.03), and low HIF-1α expression was significantly associated with isolated LR (P=.03). On multivariate logistic regression analysis, high HIF-1α was the only significant predictor of DR (odds ratio 2.46 [95% confidence interval 1.06-5.72]; P=.03). In patients with a known recurrence, an HIF-1α score ≥2.5 demonstrated a specificity of 100% for DR. CONCLUSIONS: High HIF-1α expression is a significant predictor of distant failure versus isolated local failure in patients undergoing resection of pancreatic adenocarcinoma. Expression of HIF-1α may have utility in determining candidates for adjuvant local radiation therapy and systemic chemotherapy.
Authors: David L Schwartz; Garth Powis; Arun Thitai-Kumar; Yi He; James Bankson; Ryan Williams; Robert Lemos; Junghwan Oh; Andrei Volgin; Suren Soghomonyan; Ryuichi Nishii; Mian Alauddin; Uday Mukhopadhay; Zhenghong Peng; William Bornmann; Juri Gelovani Journal: Mol Cancer Ther Date: 2009-04 Impact factor: 6.261
Authors: J P Neoptolemos; J A Dunn; D D Stocken; J Almond; K Link; H Beger; C Bassi; M Falconi; P Pederzoli; C Dervenis; L Fernandez-Cruz; F Lacaine; A Pap; D Spooner; D J Kerr; H Friess; M W Büchler Journal: Lancet Date: 2001-11-10 Impact factor: 79.321
Authors: Christine A Iacobuzio-Donahue; Baojin Fu; Shinichi Yachida; Mingde Luo; Hisashi Abe; Clark M Henderson; Felip Vilardell; Zheng Wang; Jesse W Keller; Priya Banerjee; Joseph M Herman; John L Cameron; Charles J Yeo; Marc K Halushka; James R Eshleman; Marian Raben; Alison P Klein; Ralph H Hruban; Manuel Hidalgo; Daniel Laheru Journal: J Clin Oncol Date: 2009-03-09 Impact factor: 44.544
Authors: Joal D Beane; Michael G House; Susan C Pitt; E Molly Kilbane; Bruce L Hall; Abishek D Parmar; Taylor S Riall; Henry A Pitt Journal: HPB (Oxford) Date: 2015-07-22 Impact factor: 3.647
Authors: Tara N Fujimoto; Lauren E Colbert; Yanqing Huang; Jessica M Molkentine; Amit Deorukhkar; Laura Baseler; Meifang Yu; Daniel Lin; Sonal Gupta; Peter K Cabeceiras; Charles V Kingsley; Ramesh C Tailor; Gabriel O Sawakuchi; Eugene J Koay; Helen Piwnica-Worms; Anirban Maitra; Cullen M Taniguchi Journal: Cancer Res Date: 2019-05-01 Impact factor: 12.701
Authors: Carolina J Garcia Garcia; Yanqing Huang; Natividad R Fuentes; Madeleine C Turner; Maria E Monberg; Daniel Lin; Nicholas D Nguyen; Tara N Fujimoto; Jun Zhao; Jaewon J Lee; Vincent Bernard; Meifang Yu; Abagail M Delahoussaye; Iancarlos Jimenez Sacarello; Emily G Caggiano; Jae L Phan; Amit Deorukhkar; Jessica M Molkentine; Dieter Saur; Anirban Maitra; Cullen M Taniguchi Journal: Gastroenterology Date: 2022-02-22 Impact factor: 33.883
Authors: Angela Diana; Lai Mun Wang; Zenobia D'Costa; Abul Azad; Michael A Silva; Zahir Soonawalla; Paul Allen; Stanley Liu; W Gillies McKenna; Ruth J Muschel; Emmanouil Fokas Journal: Oncotarget Date: 2016-11-08
Authors: Joni Leppänen; Olli Helminen; Heikki Huhta; Joonas H Kauppila; Joel Isohookana; Kirsi-Maria Haapasaari; Seppo Parkkila; Juha Saarnio; Petri P Lehenkari; Tuomo J Karttunen Journal: World J Surg Oncol Date: 2018-07-04 Impact factor: 2.754
Authors: David B Shultz; Jonathan Pai; Wayland Chiu; Kendall Ng; Madeline G Hellendag; Gregory Heestand; Daniel T Chang; Dongsheng Tu; Malcolm J Moore; Wendy R Parulekar; Albert C Koong Journal: PLoS One Date: 2016-01-25 Impact factor: 3.240
Authors: T Cheng; Z Jian; K Li; S Raulefs; I Regel; S Shen; X Zou; J Ruland; G O Ceyhan; H Friess; C W Michalski; J Kleeff; B Kong Journal: Oncogenesis Date: 2016-12-12 Impact factor: 7.485
Authors: Lauren E Colbert; Shalini Moningi; Awalpreet Chadha; Ahmed Amer; Yeonju Lee; Robert A Wolff; Gauri Varadhachary; Jason Fleming; Matthew Katz; Prajnan Das; Sunil Krishnan; Eugene J Koay; Peter Park; Christopher H Crane; Cullen M Taniguchi Journal: Adv Radiat Oncol Date: 2017-03-18